Nih
Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
RFA-DK-27-126: Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning Community (KUH-FAMILY) (U24 Clinical Trials Not Allowed)
NIH is seeking one RFA-DK-27-126 cooperative agreement to establish a coordinating center that builds a sustained translational learning ecosystem for kidney, urologic, and hematologic disease research through shared clinical and data infrastructure.
RFA-ES-25-002: Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
NIH's RFA-ES-25-002 invites U.S. institutions to build environmental health sciences core center infrastructure (P30), with recurring due dates in 2026 and 2027 for a long-cycle, multi-disciplinary research program.
RFA-ES-27-004: Superfund Hazardous Substance Research and Training Program (P42, Clinical Trial Optional)
NIEHS is continuing its Superfund Hazardous Substance Research and Training Program (SRP) through a multiproject P42 mechanism to fund interdisciplinary center-based hazardous substances research and training across detection, risk assessment, exposure science, and toxicity reduction.
RFA-EY-25-001: BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
NIH’s BRAIN Initiative R21 NOFO supports early-stage, high-risk technologies for neural recording and modulation with up to $400,000 total direct costs over up to three years and a strong 2026 cycle due date still open as of 2026-05-31.
RFA-HD-27-007: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research
This NIH RFA requests grant applications that use existing HIV/AIDS archives and biospecimen repositories to generate high-impact research on maternal and pediatric HIV outcomes.
RFA-HD-27-012: Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)
A limited-competition NIH renewal for existing NICHD IDDRCs, this NOFO funds interdisciplinary P50 centers advancing translational, biomarker, and real-world research for intellectual and developmental disabilities.
RFA-HG-25-009: Supporting Talented Early Career Researchers in Genomics (R01)
NIH/NHGRI reissues an R01-style NOFO for highly promising Early Stage Investigators (ESIs) building independent genomics programs, with a maximum direct-cost budget of $400,000 per year and up to a five-year project term.
RFA-HL-26-002: NHLBI Outstanding Investigator Award (OIA) 2027 R35 for HLBS Research
NHLBI’s Outstanding Investigator Award offers up to 7 years of flexible R35 support, up to $700,000 direct costs per year, with application windows that include 2026 and 2027 cycles for highly experienced investigators.
RFA-HL-26-003: NHLBI Emerging Investigator Award (EIA) (R35, Clinical Trial Optional)
NIH’s NHLBI Emerging Investigator Award (R35, clinical trial optional) supports established HLBS investigators with at least two NHLBI R01-equivalent grants for up to seven years of flexible, program-level funding, with the next listed due date on 19 February 2027.
RFA-HL-26-012: NIH StARR (R38) 2026-2027 Funding for Residency Research Programs
NIH StARR (R38) supports residency programs that give postdoctoral-level clinicians mentored research time and a path toward clinician-investigator careers.